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Abstract: Interpretation of post-mortem morphine concentrations in forensic toxicology provides sev-
eral pitfalls such as missing information on tolerance, analyte stability, or post-mortem redistribution
(PMR). Recently, it had been shown that computed tomography (CT)-guided collection of biopsies using
a robotic arm (virtobot) provides a valuable strategy for systematic studies on time-dependent PMR.
Using this technique, time-dependent PMR of morphine and its metabolites was investigated in 12 cases.
At admission to the institute (t1), femoral and heart blood (right ventricle) as well as biopsies from the
right lung, the right kidney, liver, spleen, and muscle tissue were collected. At autopsy approximately
24 h later (t2), samples from the same body regions were collected again. Additionally, gastric con-
tents, urine, brain tissue, and heart blood from the left ventricle was collected. Morphine, normorphine,
hydromorphone, morphine-3-glucuronide, morphine-6-glucuronide, and morphine-sulfate were quantified
with LC-MS/MS. In femoral blood, significant increase of morphine concentrations was observed, al-
though ultimately not relevant for forensic interpretation. In the alternative matrices, increases as well
as decreases were observed without a clear trend. The morphine metabolites did not exhibit relevant con-
centration changes. Investigation of underlying redistribution mechanisms indicated that concentration
change (i.e., increase) of morphine in femoral blood rather resulted from diffusion processes than from
release of morphine from its conjugates. Concentration changes in heart blood might have been caused
by redistribution from lung tissue or gastric content. This study also proved that CT-guided collection
of biopsies using a virtobot arm is an invaluable tool for future studies on PMR redistribution of other
substance groups.
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Interpretation of postmortem morphine concentrations in forensic toxicology provides several pitfalls such as 
missing information on tolerance, analyte stability or postmortem redistribution (PMR). Recently, it had been 
shown that computed tomography (CT) guided collection of biopsies using a robotic arm (virtobot) provides a 
valuable strategy for systematic studies on time-dependent PMR. Using this technique, time-dependent PMR of 
morphine and its metabolites was investigated in 12 cases. At admission to the institute (t1), femoral and heart 
blood (right ventricle) as well as biopsies from the right lung, the right kidney, liver, spleen and muscle tissue 
were collected. At autopsy approximately 24 h later (t2), samples from the same body regions were collected 
again. Additionally, gastric contents, urine, brain tissue and heart blood from the left ventricle was collected. 
Morphine, normorphine, hydromorphone, morphine-3-glucuronide, morphine-6-glucuronide and morphine-
sulfate were quantified with LC-MS/MS. In femoral blood, significant increase of morphine concentrations was 
observed, although ultimately not relevant for forensic interpretation. In the alternative matrices, increases as 
well as decreases were observed without a clear trend. The morphine metabolites did not exhibit relevant 
concentration changes. Investigation of underlying redistribution mechanisms indicated, that concentration 
change (i.e. increase) of morphine in femoral blood rather resulted from diffusion processes than from release of 
morphine from its conjugates. Concentration changes in heart blood might have been caused by redistribution 
from lung tissue or gastric content. This study also proved that CT-guided collection of biopsies using a virtobot 
arm is an invaluable tool for future studies on PMR redistribution of other substance groups. 






Interpretation of postmortem morphine concentrations in forensic toxicology provides several pitfalls. Besides 
antemortem factors such as missing information on opiate tolerance or duration of an agonal phase, postmortem 
factors such as analyte stability or postmortem redistribution (PMR) have to be considered. If available, hair 
analysis may be useful to gather information on drug history. PMR of morphine might be caused by diffusion 
processes along concentration gradients, instability or bacterial conversion of morphine-conjugates to morphine 
[1,2]. To date, several in vitro experiments on analyte stability and vascular permeation of morphine were 
performed to clarify its redistribution mechanisms [1,3-5]. Unfortunately, only few studies on analyte stability 
were performed in postmortem specimen. Moriya et al. found morphine and its conjugates to be stable in 
postmortem blood at 37 °C for 10 days [1], whereas Carrol et al. found conversion of morphine-3-glucuronide 
(M3G) to morphine at 37 °C in postmortem blood within 2 weeks [3]. However, a temperature of 37 °C might 
not reflect environmental temperature for most cases in the postmortem interval. Skopp et al. showed that 
morphine concentrations in postmortem blood increased within 124 days at 20 °C and the morphine-glucuronide 
concentrations decreased correspondingly [6]. In addition, the morphine glucuronide stability seemed to be 
dependent on environmental temperature and the degradation was accelerated by light exposure. Considering 
the described studies, morphine conjugate stability might differ from case to case as contributing factors such as 
microbiological load, environmental temperature or light exposure may differ inter-individually. Vascular 
permeation of morphine and its glucuronides was shown to start after a lag time and to be dependent on the 
disintegration of the vascular wall, the temperature and the concentration gradient [5]. Consequently, analyte 
instability as well as diffusion processes might be involved in postmortem morphine concentration changes. In 
vivo investigation of time-dependent PMR of morphine and its metabolites was performed on animal models 
and in human case studies. Studies in rat, rabbit and pig model revealed relevant concentration increases of free 
morphine in blood and other matrices within minutes to days after death [7-10]. In contrast, time-dependent 
PMR studies on human cases indicate that morphine and its metabolites do not undergo significant postmortem 
concentration changes in peripheral blood [11-14]. However, the investigated time intervals mostly did not 
include the first few hours after death, where high concentration changes are believed to occur. Tolliver et al. 
compared antemortem to postmortem morphine concentrations and found increased postmortem concentrations 
in 5 of 7 cases mostly in central blood specimen [15]. In conclusion, it remains unclear whether postmortem 
morphine blood concentrations can be assumed to represent antemortem concentrations, especially as 
concentration changes within the first minutes and hours after death were not investigated in human cases so far. 
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Next to the lack of information on PMR in the postmortem interval (PMI) few hours after death, concentration 
changes in alternative matrices such as organs and tissues have not been investigated in humans to date. In 
rabbit liver, lung or kidney tissue, postmortem increases as well as decreases were observed for morphine and 
M3G [10]. The aim of our study was to further clarify time-dependent PMR and its mechanisms of morphine 
including its metabolites not only in blood but also in alternative matrices such as muscle, liver, kidney, lung, 
spleen and adipose tissue in humans. Especially the application of CT-guided biopsy sampling hours before 
conventional autopsy should provide valuable information on drug concentration changes in alternative matrices 
[16]. 
Materials and methods 
Chemicals and reagents 
Methanolic solutions of morphine, M3G, morphine-6-glucuronide (M6G), normorphine, hydromorphone and 6-
monoacetylmorphine (MAM) (1 mg/mL) and the deuterated internal standards (IS) morphine-d3, M3G-d3, 
M6G-d3 and MAM-d3 (0.1 mg/mL) were obtained from Cerilliant (delivered by Sigma-Aldrich, Buchs, 
Switzerland). Water was purified with a Purelab Ultra millipore filtration unit (Labtech, Villmergen, 
Switzerland) and acetonitrile of HPLC grade was obtained from Fluka (Buchs, Switzerland). All other 
chemicals used were from Merck (Zug, Switzerland) and of the highest grade available.  
Postmortem samples 
Blood and alternative matrices were collected at two time points t1 and t2 after death within the routine 
toxicological investigation according to [16]. After the routine postmortem CT imaging procedure (t1) on a 128-
slice scanner (Somatom Definition Flash, Siemens Medical Solutions, Forchheim, Germany), introducer needles 
were placed into the right heart ventricle, the right lung, the right lobe of the liver, the right kidney, the spleen, 
subcutaneous adipose tissue of the waist, muscle tissue at the upper left thigh and the right femoral vein using 
the virtobot system [16,17]. After placement of the introducer needles, another CT scan was performed to verify 
needle positions. From the right heart ventricle and the femoral vein, 1 mL blood was collected each. Biopsies 
were collected in triplicates from all mentioned matrices. Directly after sample collection, the biopsies were 
weighed into 2 mL Metal Bead Lysing Matrix tubes (MP Biomedicals, Illkirch, France). The body fluids were 
aliquoted into 2 mL Eppendorf Safe Lock Tubes (Schoenenbuch, Switzerland) in triplicates of 20 µL for 
morphine quantitation and into duplicates of 100 µL for morphine metabolite quantitation. The following day at 
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autopsy (t2), samples from the same locations were collected where biopsies had been taken at t1. Additionally, 
heart blood from the left ventricle, urine, gastric content and cerebellum were collected. After autopsy, the solid 
matrices were aliquoted into triplicates of approx. 20 mg and body fluids into triplicates of 20 µL for morphine 
quantitation. The blood samples additionally were aliquoted into duplicates of 100 µL for morphine metabolite 
quantitation. All samples were stored at -20 °C until analysis.  
Quantitation of morphine 
All samples belonging to the same case were extracted and analyzed on the same day. Sample preparation and 
analysis of morphine was performed according to Staeheli et al. [18]. Briefly, tissue samples were homogenized 
and two liquid-liquid extractions (LLE) with butyl acetate/ethyl acetate (1:1, v/v) were performed, one at pH 7.4 
and one at pH 13.5. The extracts were combined and analyzed by an LC-MS/MS method, which was previously 
validated in postmortem femoral blood (pB), heart blood (HB), muscle, liver, kidney, spleen, lung, brain and 
adipose tissue [18]. 
Quantitation of morphine metabolites 
The morphine metabolites M3G, M6G, normorphine (NM), hydromorphone (HM), morphine-3-sulfate (M3S) 
and morphine-6-sulfate (M6S) were quantified in pB and HB samples. Blood samples were extracted by solid 
phase extraction (SPE) adapted from [19]. Briefly, 100 µL blood were fortified with an IS mixture containing 
morphine-d3 75 ng/mL, MAM-d3 50 ng/mL, M3G-d3 400 ng/mL and M6G-d3 500 ng/mL and diluted with 1 
mL 0.5 M carbonate buffer pH 9.3. The sample was loaded onto a preconditioned (2 mL methanol, 2 mL H2O, 1 
mL 5 mM carbonate buffer pH 9.3) BakerBond C18 200 mg 3 mL SPE column (Avantor Performance 
Materials, Deventer, Netherlands). The column was washed with 1 mL 5 mM carbonate buffer pH 9.3, dried for 
1 min under vacuum and elution was performed with 1.5 mL MeOH. The eluate was evaporated to dryness 
under a gentle stream of nitrogen at 40 °C and reconstituted in 50 µL of a mixture of eluent A and B (5:95 v/v). 
The analysis was performed using the same LC-MS/MS instrument mentioned in the previous chapter. The LC 
settings were as follows: Merck (Darmstadt, Germany) SeQuant® ZIC®-HILIC column (150 x 2.1 mm, 3.5 
µm), gradient elution with eluents A and B, start conditions 95% B for 0.5 min with a flow rate of 0.5 mL/min, 
1-7 min concave downward to 10% B, hold at 10% B for 0.5 min and reequilibrating to 95% B for 1.5 min. 
Injection volume was 10 µL. The MS was operated in the MRM mode using three transitions for each analyte. 
MRM 3 corresponded to the 13C isotope of MRM 1 to extend the dynamic range of the method in case of high 
concentrations [18]. The MS settings for each analyte are given in Table 1. Calibrator and quality control (QC) 
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samples were prepared using blank postmortem pB samples spiked with 20 µL calibration spiking solution and 
25 µL IS spiking mix. Calibration range was 4-4000 ng/mL for M3G, 10-1600 ng/mL for M6G, 1-300 for NM 
and 0.5-300 for HM. QC concentration was defined 20% above lowest calibrator for QC low, 20% below 
highest calibrator for QC high and 80% below highest calibrator for QC med. The regressions were calculated 
using a simple linear model with 1/X weighting. All metabolites were quantified using MRM 1. Morphine-
sulfate identity was confirmed with a high resolution mass spectrum using the described chromatographic 
method and a Sciex 6600 QTOF system. Additionally, reversed-phase chromatography was performed and 
elution order of M3S resp. M6S was compared to Andersson et al. [20]. 
 
Data analysis 
PMR of morphine and its metabolites 
Distribution of morphine at t1 was evaluated as concentration ratio of each matrix to pB. Percent concentration 
differences between t1 and t2 were calculated for morphine, M3G, M6G, M3S and NM defining mean 
concentration at t1 as 100%. For statistical evaluation a non-parametric Wilcoxon matched-pairs signed ranks 
test (p<0.05) was applied between t1 and t2 using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, 
USA). 
PMR mechanisms: diffusion processes 
The percentage concentration change per hour relative to the concentration at t1 (mc) was calculated for pB, HB 
and spleen according to 
(1) 𝑚𝑐 = 100𝑐𝑡1 ∗  𝑐𝑡2−𝑐𝑡1𝑑𝑡 ,  
ct1 = mean morphine concentration at t1 [ng/mL]; ct2 = mean morphine concentration at t2 [ng/mL]; dt = time 
interval between t1 and t2 [h] 
The lung-to-HB (right ventricle) concentration ratio at t1 as well as the gastric content-to HB (right ventricle) 
concentration ratio at t2 were compared with the percentage concentration change in HB (right ventricle) (mcHB). 
Additionally, the lung-to-HB (right ventricle) concentration ratio at t1 was compared with the concentration 
ratio between HB from the left ventricle and HB from the right ventricle at t2. The muscle-to-pB as well as the 
HB-to-pB concentration ratio (i.e. central to peripheral ratio; C/P-ratio) at t1 was compared to the percentage 
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concentration change in pB (mcpB). The concentration ratio between stomach content (t2) and spleen (t1) was 
compared to the percentage concentration change in spleen (mcspleen). Nonparametric Spearman correlation 
coefficients were calculated using GraphPad Prism 6.  
PMR mechanisms: conjugate stability 
The molar concentration change of M3G was compared to the molar concentration change of morphine in pB 
and HB. The percentage change of the area ratio of M3S was compared with the percentage concentration 
change of morphine in pB and HB. Nonparametric Spearman correlation coefficients were calculated using 
GraphPad Prism 6.  
 
Results and discussion  
Time-dependent PMR and distribution of morphine and its metabolites was investigated in blood and alternative 
matrices of 12 cases within a PMI of 6 to 88 h (Table 2). CT-guided biopsy sampling was applied before actual 
autopsy to provide 2 time points for investigation of PMR. PMI until first sampling time point ranged from 6 to 
63 h and the time interval between first and second sampling ranged from 18 to 29 h. In 7 cases morphine 
resulted from a heroin application and in the other cases most probably from a morphine intake or application. 
In most cases cause of death was of toxicological nature, except for case 6 who died of an acute cardiac 
infarction. 
Concentrations and redistribution of morphine 
Morphine concentrations in all matrices are displayed as concentration ratio to pB, where concentrations ranged 
from not detectable to 2500 ng/mL (Fig. 1). In case 6, morphine was below LOQ in all samples except for 
muscle, liver and lung at t1. Distribution of morphine was rather inhomogeneous with highest concentrations in 
lung, liver, kidney and gastric content. These findings are in line with previous publications [21,22]. In muscle 
tissue, concentrations were 1.2 to 3.9 times higher compared to pB and thus closest to pB within the alternative 
matrices. Due to the relatively narrow range of morphine concentration ratio to pB, muscle from the upper thigh 
might therefore be a recommendable alternative to pB in cases where pB is not available.  
Time-dependent redistribution of morphine was investigated comparing concentration at t1 with t2 (Fig. 2). In 
pB, a morphine concentration increase was observed in all cases (range 0.4-240%, mean 65%, median 44%). 
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Morphine concentration change in pB was significant (p<0.05) in contrast to previous studies [11-14]. However, 
in none of the cases the toxicological interpretation had to be altered regarding morphine concentration at t1. 
Therefore, the concentration increases were considered as not relevant for case interpretation. In general, 
statistical significance of the observed concentration changes should be interpreted with caution, as inter-
individual differences in postmortem cases are usually great.  
In all other matrices, concentration increases as well as decreases were observed with ranges of -5 to 680% 
(median 37%) in HB, -100 to 160% (median -3.1%) in liver, -59 to 170% (median -20%) in kidney, -100 to 26% 
(median -24%) in muscle, -10 to 155% (median 9.5%) in spleen and -100 to 300% (median -8.6%) in lung tissue 
(Fig. 2). In adipose tissue, concentration ranges of t1 and t2 were overlapping in the majority of the cases and 
therefore, changes in concentration could not be assumed. PMR in kidney was not displayed as concentrations 
within the time points varied widely. Further experiments showed that drug concentrations in the kidney 
medulla and cortex differed (data not shown). As it was not possible to distinguish between cortex and medulla 
during sampling, this might have been the reason for the variations. In case 1, highest concentration changes 
were observed in the majority of matrices compared to the other cases. As case 1 reported the shortest PMI 
compared to the other cases, this study might support the theory of PMR mainly occurring in the first few hours 
after death. However, Hargrove et al. who reported even shorter intervals before first sampling did not observe 
significant concentration changes [11].  
 
Concentrations and redistribution of morphine metabolites  
The morphine metabolites were quantitated with a separate LC-MS/MS method because the recovery of the 
morphine-conjugates was insufficient with the LLE used for the quantitation of morphine in all matrices. 
Chromatography of the LC-MS/MS method for the morphine metabolites is displayed in Fig. 3. Although 
quantitation of MAM was not aimed for, it was included into the method to prove chromatographic separation. 
As the morphine-sulfate metabolites were not commercially available, identity was confirmed by high resolution 
mass spectrum and comparison of the M3S and M6S elution order in authentic cases with published work from 
Andersson et al. [20].The high resolution mass spectrum of M3S ([M+H] 366.1013 Da, mass error 1.9 ppm) 
included the [M+H] fragments 286.1459, 268.1332, 201.0915, 185.0594 and 165.0717 Da thus proving 
morphine-sulfate identity. M3S was shown to occur in higher concentrations than M6S, leading to the 
assumption that the first eluting peak represents M3S [20] Additional experiments with reversed-phased 
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chromatography showed that M3S and M6S eluted in the same order as in the HILIC-chromatography. 
Comparison of the morphine-sulfates elution order with published work from Andersson et al. further confirmed 
assignment of M3S and M6S [20]. However, as M6S was not detectable in many cases and signal to noise ratios 
were generally low, only results for M3S are discussed. As also HM concentrations were below LOD in most 
cases, they were not discussed either. As primarily concentration changes and therefore relative concentrations 
were of importance for the presented work, metabolite quantitation without full method validation was 
considered acceptable. Additionally, the use of deuterated internal standards and the comparison of 
concentration in matrices from the same individuals should further reduce a possible lack of precision or 
accuracy.  
Morphine metabolite percentage concentration changes in pB were minor in most cases. However, concentration 
increases as well as decreases were observed (Fig. 4). Concentration changes ranged from -66 to 49% (median -
12%) for M3G, -15 to 86% (median 5.3%) for M6G, -12 to 280% (median 3.1%) for NM and -43 to 180% 
(median 4.3%) for M3S in pB. In HB, concentration changes of the metabolites were greater compared to those 
in pB (Fig. 4). Median changes were 15% for M3G, -1.2% for M6G, 1.2% for NM and 70% for M3S. 
Especially for the morphine conjugates, no significant decrease could be observed. This leads to the conclusion 
that conjugate instability was not a major problem in the selected cases. However, storage of the bodies at 5 °C 
between the sampling time points did not reflect natural environment and might have supported analyte stability. 
 
Redistribution mechanisms 
As significant morphine concentration changes were observed in this study, possible redistribution mechanisms 
were evaluated, especially diffusion processes and release from conjugate metabolites. Diffusion processes were 
already shown to contribute to postmortem concentration changes for other drugs [23]. Therefore, morphine 
concentration changes were correlated to concentration ratios to adjacent tissues. In addition, the role of the C/P-
ratio as a marker for PMR was evaluated. To compensate for inter-individual differences in PMI, the 
concentration change was divided by the PMI, although linearity of concentration changes could not be 
assumed. 
High C/P-ratios were stated to be a marker for PMR processes [24]. However, Spearman correlation of the C/P-
ratio of morphine to concentration change in pB (mcpB) was only weak (Fig. 5a). Therefore, a high C/P-ratio 
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might not be a valuable indicator for postmortem concentration changes in case of morphine. Concentration 
increases in pB might have been caused by diffusion from adjacent muscle tissue, as a concentration gradient 
was observed in all cases (Fig 1). Therefore, the concentration ratio of morphine in muscle from the upper thigh 
to pB was compared to mcpB and a moderate positive correlation was observed (Fig. 5b). Skopp et al. showed 
that vascular permeation can occur for morphine and its metabolites [5]. Although permeation was found to be 
mainly dependent on the disintegration of the vascular wall and the PMI, it was stated that permeation might 
even occur at early postmortem stages. Consequently, morphine diffusion from muscle to pB seems to be likely, 
especially in cases with high concentration ratios between muscle and pB. However, diffusion along the blood 
vessels cannot be excluded as concentrations distal or proximal to the sampling point were not investigated. 
In cases where no pB and appropriate alternatives are available, HB is sometimes used for drug quantitation. 
However, interpretation of concentrations in HB provides several pitfalls. Concentrations are often higher 
compared to pB and several redistribution mechanisms are discussed, such as diffusion from gastric content, 
heart muscle or lung tissue [2]. Although concentration changes generally were not statistically significant in 
HB in our study, individual cases exhibited relatively great concentration changes. Therefore, concentration 
changes in HB (mcHB) were compared to the concentration ratios between lung and HB (Fig 5c) and to the ratio 
between gastric content and HB (Fig 5d). Morphine concentration in HB of case 1 and in gastric content of case 
7 and 9 exceeded the calibration range at t2. Therefore, Spearman coefficient r* was calculated with exclusion 
of these cases. Weak to moderate positive correlation was found in both comparisons, thus redistribution from 
gastric content and lung to HB appears to be possible. Furthermore, correlation of ratio between lung and HB 
was compared to the concentration ratio between HB from the left and the right ventricle (Fig 5e). It showed 
moderate to strong positive correlation. These findings strongly support the theory of redistribution from the 
lung to the left heart via the pulmonary veins. Unfortunately, concentrations in heart muscle were not 
determined and therefore redistribution from heart muscle cannot be excluded.  
Postmortem morphine concentration changes in spleen might not be relevant in the majority of the forensic 
cases. Nevertheless, diffusion processes from gastric content was investigated as the spatial proximity to spleen 
let it seem plausible (Fig 5f). The observed moderate to strong positive correlation supported this theory. 
Besides diffusion processes, conjugate instability is discussed as cause for potential postmortem concentration 
changes, as morphine is released from its conjugates. Therefore, M3G and M3S concentration changes were 
correlated with the morphine concentration change in pB and HB (Fig. 6). In case of morphine conjugate 
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instability, negative correlation between concentration change of the conjugates and morphine would be 
expected. In our study, no correlation was observed in pB and even strong positive correlation in HB. 
Consequently, it can be stated that conjugate instability did not lead to morphine increase in pB or HB. 
Moreover, M3G and M3S in HB rather seemed to be redistributed with comparable mechanisms like morphine 
itself. Carrupt et al. showed that the morphine glucuronides are only slightly less lipophilic compared to 
morphine, which might be a factor contributing to the similar postmortem behaviour of M3G and morphine 
[25]. 
Conclusions 
Significant morphine concentration increase was observed in pB, however, the concentration changes were not 
relevant regarding interpretation of the forensic cases. In the alternative matrices, increases as well as decreases 
were observed without a clear trend. Metabolites did not undergo extensive PMR. Especially the conjugates 
were shown to be rather stable, thus not contributing to morphine concentration increase in pB. The latter might 
rather have been caused by diffusion processes from e.g. surrounding muscle tissue. Investigation of HB and 
lung resp. gastric content supported the theory of redistribution along pulmonary veins to the left heart ventricle 
or from stomach to the heart. Moreover, CT-guided biopsy sampling proved to be a valuable tool for 
investigation of PMR mechanisms. 
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Tables 
Table 1 MS settings for the quantitation of the morphine metabolites including Q1 mass, Q3 mass, dwell time, 
analyte name, declustering potential (DP), entrance potential (EP), collision energy (CE) and collision cell exit 















286.1 152.1 10 Morphine 1 156  81 14 
286.1 165.1 10 Morphine 2 156  57 16 
287.1 153.1 10 Morphine 3 156  81 14 
328.0 165.0 10 MAM 1 141  49 20 
328.0 210.9 10 MAM 2 141  35 16 
329.0 166.0 10 MAM 3 141  49 20 
286.1 185.0 50 HM 1 176  39 16 
286.1 157.1 10 HM 2 176  55 14 
287.1 186.0 10 HM 3 176  39 16 
462.2 286.1 100 M3G 1 106  39 16 
462.2 201.2 10 M3G 2 106  55 12 
463.2 287.1 10 M3G 3 106  39 16 
462.2 286.1 100 M6G 1 36  43 22 
462.2 165.0 10 M6G 2 36  79 18 
463.2 287.1 10 M6G 3 106  39 16 
366.2 286.1 100 M3S 1 106  39 16 
366.2 201.2 10 M3S 2 106  55 12 
366.2 286.1 100 M6S 1 106  39 16 
366.2 201.2 10 M6S 2 106  55 12 
272.2 152.1 50 NM 1 111  79 12 
272.2 165.1 10 NM 2 111  57 12 
273.2 153.1 10 NM 3 111  79 12 
289.0 152.1 10 Morphine-d3 156  75 18 
331.1 165.2 10 MAM-d3 196  53 16 
465.2 289.1 10 M3G-d3 106  39 16 






Table 2 Case circumstances including the postmortem interval (PMI) between death and first sampling time 
point (PMI t1), time between first and second sampling time point (dt), cause of death, involved opiate and other 
drugs detected. In case 5 and 11, no information on antemortem heroin or morphine use was available. As there 






Cause of death Opiate Other relevant drugs 
1 6 (4.5-6) 21 Opiate intoxication  Heroin 
Trimipramine, methylphenidate, 
hydroxyrisperidone, MAM 
2 47 20 
Combined ethanol, opiate and 
diazepam intoxication 
Heroin 
Diazepam, cocaine, amisulpride, 
MAM 
3 28 26 
Combined oxycodone and 
midazolam intoxication 
Morphine Midazolam, oxycodone 









Mirtazapine, zolpidem, cocaine 
6 48 20 
Combined ethanol and 
zolpidem intoxication 
Morphine 
Diazepam, trazodone, lorazepam, 
quetiapine 
7 27 (19-35) 29 Opiate intoxication Heroin Alprazolam, cocaine, methadone 




9 27 27 
Combined midazolam, 





10 32 23 
Combined ethanol, oxazepam 
and opiate intoxication 
Heroin 
Trazodone, quetiapine, 
clotiapine, codeine, MAM 














Fig. 1 Distribution of morphine displayed as concentration ratio to femoral blood, each dot representing one 
case and the line representing the median ratio. In cases where concentration at t1 was not available, 








Fig. 2 PMR of morphine in femoral blood, heart blood (right ventricle), muscle, liver, lung and spleen displayed 
as concentration vs. the postmortem interval (PMI). Each dot represents one sample of the triplicate 





Fig. 3 LC-MS/MS chromatogram of the morphine metabolites quantitation method including 6-
monoacetylmorphine (MAM, 328→165), hydromorphone (HM, 286→185), morphine, morphine-3-sulfate 
(M3S, 366→286), normorphine (NM, 272→152), morphine-6-sulfate (M6S, 366→286), morphine-6-
glucuronide (M6G, 462→286) and morphine-3-glucuronide (M3G, 462→286). Quantitation of morphine was 






Fig. 4 PMR of a) morphine-3-glucuronide (M3G); b) morphine-6-glucuronie (M6G) and c) normorphine (NM) 
in femoral and heart blood (right ventricle) displayed as concentration vs. the postmortem interval (PMI). Each 
19 
 
dot represents one sample of the triplicate measurements. The mean concentration at the sampling time points t1 






Fig. 5 Evaluation of redistribution mechanisms of morphine in femoral blood (pB), displayed as the muscle-to-
pB concentration ratio (a) and the C/P-ratio (b) compared to the morphine concentration increase in pB (mcpB). 
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Evaluation of redistribution mechanisms in heart blood (HB) displayed as the lung-to-HB concentration ratio (c) 
as well as the gastric content-to-HB ratio (d) compared to the morphine concentration increase in HB (mcHB). 
Additionally, the lung-to-HB concentration ratio was compared to the HB concentration ratio between left and 
right ventricle (e). Gastric content-to-spleen concentration ratio was compared to the concentration increase in 











Fig. 6 Evaluation of redistribution of morphine in femoral (pB) and heart blood (HB) due to conjugate 
instability: molar concentration change of morphine compared to molar concentration change of M3G in pB (a) 
and HB (c) and percentage concentration change of morphine compared to the percentage concentration change 
of morphine-sulfate in pB (b) and HB (d). Spearman correlation coefficient r is shown (r* with exclusion of 
cases exceeding the calibration range). 
 
 
 
